NORLEN; Per
Patent Applications and Registrations
Patent applications and USPTO patent grants for NORLEN; Per.The latest application filed is for "novel bispecific polypeptides against cd137".
- NORLEN; Per - Lund SE
- NORLEN; Per - Limhamn SE
| Patent | Date |
|---|---|
| Novel Bispecific Polypeptides Against Cd137 App 20220213213 - DAHLEN; Eva ; et al. | 2022-07-07 |
| Combination Therapies With Anti Cd40 Antibodies App 20210403589 - Ellmark; Peter ; et al. | 2021-12-30 |
| Combination therapies with anti CD40 antibodies Grant 11,149,090 - Ellmark , et al. October 19, 2 | 2021-10-19 |
| Novel Polypeptides App 20210238298 - Ellmark; Peter ; et al. | 2021-08-05 |
| Polypeptides Grant 11,008,396 - Ellmark , et al. May 18, 2 | 2021-05-18 |
| Polypeptides Grant 10,774,150 - Ellmark , et al. Sept | 2020-09-15 |
| Novel Polypeptides App 20200190208 - Ellmark; Peter ; et al. | 2020-06-18 |
| Bispecific Antibody Against Ox40 And Ctla-4 App 20200048358 - Ellmark; Peter ; et al. | 2020-02-13 |
| Bispecific Polypeptides to GITR and CTLA-4 App 20190309084 - Ellmark; Peter ; et al. | 2019-10-10 |
| Novel Bispecific Polypeptides Against Cd137 App 20190169308 - Dahlen; Eva ; et al. | 2019-06-06 |
| Bispecific Antibodies Directed Against OX40 and a Tumor-Associated Antigen App 20190161555 - Ellmark; Peter ; et al. | 2019-05-30 |
| Novel Polypeptides App 20180118841 - Ellmark; Peter ; et al. | 2018-05-03 |
| Bispecific Molecules Capable Of Specifically Binding To Both Ctla-4 And Cd40 App 20170304437 - ELLMARK; Peter ; et al. | 2017-10-26 |
| Combination Therapies With Anti Cd40 Antibodies App 20170226217 - Ellmark; Peter ; et al. | 2017-08-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 